You're signed outSign in or to get full access.
About
John Barrett, Ph.D., is an Analyst on the Public Equity team at Sofinnova Investments, based in Boston, MA. In his current role, he focuses on public biotech investments across all therapeutic areas, leveraging his advanced scientific background to evaluate and support portfolio decisions in the biotechnology sector.
Barrett's investment career encompasses roles as an Analyst at Parkman Healthcare Partners, where he covered small and mid-cap biotechnology companies across diverse therapeutic areas, and as Vice President at SVB Leerink, specializing in equity research for SMid cap oncology firms. These positions have given him broad expertise in public equity markets and a strong track record in healthcare and biotechnology investment analysis.
He holds a Ph.D. in Molecular Engineering from the University of Chicago and a B.S. in Biomedical Engineering with a nanotechnology concentration from Boston University. Barrett's rigorous technical education and global research experience underpin his analysis of innovative therapeutics and emerging biotech trends, making him a specialized asset in biotechnology public market investing.
Career History
| Organization | Role | Date Range | Details |
|---|---|---|---|
| Sofinnova Investments | Analyst | Aug 2024 to Present | — |
| Parkman Healthcare Partners LLC | Analyst | Mar 2021 to Dec 2023 | — |
| SVB Leerink | Vice President, Biotechnology Equity Research | Feb 2020 to Mar 2021 | — |
| SVB Leerink | Associate, Biotechnology Equity Research | Mar 2018 to Feb 2020 | Associate of Jonathan Chang - named Rising Star in Institutional Investor’s 2018 All-America Research Team for Biotechnology/Mid- & Small-Cap
Coverage Area: Emerging Oncology
Series 7, 63, 86, 87 |
| Synlogic Therapeutics | Research Strategy and Business Development Intern | May 2017 to Sep 2017 | - Collaborated with Executive Director of Corporate Development to position Synlogic as a preferred strategic partner
- Delivered meaningful and actionable information to inform company strategy based... |
| Aspire Capital Partners | Biotech Equity Research Intern | Sep 2016 to Jul 2017 | Perform market research and due diligence on small- and mid-cap public biotech companies for potential investment. Analysis aimed at a holistic understanding of company pipeline and therapeutic portfo... |
| George Shultz Innovation Fund | Venture Capital Associate | Sep 2015 to Dec 2016 | • Perform due diligence, financial modeling, and market research for proof-of-concept University
ventures on a multidisciplinary team of business, law, and undergraduate students
• Identify key risk i... |
| Eastern Standard Kitchen and Drinks | Bar Back | Sep 2010 to Aug 2013 | — |
Education
The University of Chicago
Ph.D., Molecular Engineering
2013 — 2017
Boston University
B.S, Biomedical Engineering; Concentration: Nanotechnology
2009 — 2013
Technische Universitat Dresden
Biomedical Engineering Study Abroad Program
2011 — 2011
West Seneca East Senior
Project Lead the Way - Engineering Curriculum
2005 — 2009
Others at Sofinnova Investments, Inc. (12)
| Name | Role | Location |
|---|---|---|
 | Analyst | New York, NY , United States |
 | Partner | New York, NY , United States |
 | General Partner | CA , United States |
 | Analyst | CA , United States |
S Sarah Bhagat | General Partner | Menlo Park, CA , United States |
A Ace Isidro | Associate | Boston, MA , United States |
 | Analyst | Boston, MA , United States |
 | Managing Partner | United States |
 | Fund Manager | Ashburn, VA , United States |
M Mike Van | Associate | Stanford, CA , United States |
Similar Fund Managers
| Name | Role | Fund | Location |
|---|---|---|---|
 | Partner | Decheng Capital LLC | San Francisco, CA , United States |
 | Partner | Decheng Capital LLC | New York, NY , United States |
 | Principal | Crosslink Capital Inc. | CA , United States |
D Dane Lewis | Analyst | Crosslink Capital Inc. | San Francisco, CA , United States |
